热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　摩根士丹利发布研究报告称，下调康龙化成（03759）目标价3.7%，从24.2港元至23.2港元，维持“增持”评级。

　　大摩表示，下调康龙化成2024年纯利增长预测3.3%，2025年削2.4%，2026年微升0.4%，其中收入数字大体不变，海外业务毛利率改善速度略有放缓。对该公司2024-2025年经调整纯利预测调低3.7%/2.2%，至15.7/18.8亿元人民币（下同），2026年预测上调0.4%至24.1亿元。

　　大摩同时调整对该公司2027年及之后的资本开支假设，从10-15亿元，降至10亿元以上，以反映中国小分子药品委托开发暨制造服务（CDMO）中期前景更光明。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：史丽君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.